Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  144,722 results for ""Factor X""

Your Filters

Language : english
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Cerebral infarction in a patient with inhibitor-positive hemophilia B treated with plasma-derived factor VIIa and factor X mixture.

  • Authors : Shimozawa K; Paediatrics, Nihon University Itabashi Hospital, 30-1 Oyaguchi kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan.; Yagasaki H

Subjects: Cerebral Infarction*/Cerebral Infarction*/Cerebral Infarction*/etiology ; Cerebral Infarction*/Cerebral Infarction*/Cerebral Infarction*/blood ; Factor VIIa*/Factor VIIa*/Factor VIIa*/therapeutic use

  • Source: Annals of hematology [Ann Hematol] 2024 Jun; Vol. 103 (6), pp. 2161-2162. Date of Electronic Publication: 2024 Apr 13.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Fitusiran reduces bleeding in factor X-deficient mice.

  • Authors : Verhenne S; Université Paris-Saclay, INSERM, Hémostase Inflammation Thrombose HITh U1176, Le Kremlin-Bicêtre, France.; McCluskey G

Subjects: Factor X*/Factor X*/Factor X*/metabolism ; Factor X*/Factor X*/Factor X*/genetics ; Factor X Deficiency*/Factor X Deficiency*/Factor X Deficiency*/genetics

  • Source: Blood [Blood] 2024 Jul 11; Vol. 144 (2), pp. 227-236.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

Record details

Read More Add to Saved list
×
Academic Journal

Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors.

  • Authors : Schreuder M; Department of Internal Medicine, Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.; Jourdi G

Subjects: Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/pharmacology ; Rivaroxaban* ; Blood Coagulation*/Blood Coagulation*/Blood Coagulation*/drug effects

  • Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Aug; Vol. 22 (8), pp. 2211-2226. Date of Electronic Publication: 2024 May 09.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836

Record details

Read More Add to Saved list
×
Academic Journal

Reduced plasma factor X is associated with a lack of response to recombinant activated factor VII in patients with hemophilia A and inhibitor, but does not impair emicizumab-driven hemostasis in vitro.

  • Authors : Yada K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan. Electronic address: .; Fujitate N

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/pharmacology ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use

  • Source: Thrombosis research [Thromb Res] 2024 May; Vol. 237, pp. 37-45. Date of Electronic Publication: 2024 Mar 22.Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

The emicizumab-bridged ternary complex with activated factor IX and factor X evaluated by fluorescence resonance energy transfer.

  • Authors : Oda A; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.; Takeyama M

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Factor IXa*/Factor IXa*/Factor IXa*/metabolism

  • Source: Thrombosis research [Thromb Res] 2024 May; Vol. 237, pp. 108-111. Date of Electronic Publication: 2024 Apr 01.Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Kinetics and regulation of coagulation factor X activation by intrinsic tenase on phospholipid membranes.

  • Authors : Sveshnikova AN; National Medical and Research Center of Pediatric Hematology, Oncology and Immunology Named After Dmitry Rogachev, 1 Samory Mashela St, Moscow, 117198, Russia; Faculty of Fundamental Physico-Chemical Engineering, Lomonosov Moscow State University, 1/51 Leninskie Gory, 119991 Moscow, Russia

Subjects: Factor X*/Factor X*/Factor X*/metabolism ; Phospholipids*/Phospholipids*/Phospholipids*/metabolism ; Neoplasm Proteins*

  • Source: Journal of theoretical biology [J Theor Biol] 2024 Apr 07; Vol. 582, pp. 111757. Date of Electronic Publication: 2024 Feb 07.Publisher: Elsevier Country of Publication: England NLM ID: 0376342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-8541

Record details

Read More Add to Saved list
×
Academic Journal

Plasma-derived human factor X concentrate for the treatment of patients with hereditary factor X deficiency.

  • Authors : Escobar MA; University of Texas Health Science Center at Houston-McGovern Medical School and the Gulf States Hemophilia and Thrombophilia Center, Houston, Texas, USA.; Kavakli K

Subjects: Factor X*/Factor X*/Factor X*/therapeutic use ; Factor X*/Factor X*/Factor X*/adverse effects ; Factor X Deficiency*/Factor X Deficiency*/Factor X Deficiency*/complications

  • Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2024 Jan; Vol. 30 (1), pp. 59-67. Date of Electronic Publication: 2023 Oct 30.Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Preclinical development and characterization of a human plasma-derived high-purity factor X concentrate for therapeutic use.

  • Authors : Lloyd J; Research & Development Department, Bio Products Laboratory, Dagger Lane, Elstree, UK.; Feldman P

Subjects: Factor X*/Factor X*/Factor X*/therapeutic use ; Factor X Deficiency*/Factor X Deficiency*/Factor X Deficiency*/drug therapy ; Factor X Deficiency*/Factor X Deficiency*/Factor X Deficiency*/complications

  • Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2023 Nov; Vol. 29 (6), pp. 1394-1409. Date of Electronic Publication: 2023 Sep 27.Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Different modeling approaches in the simulation of extrinsic coagulation factor X activation: Limitations and areas of applicability.

  • Authors : Kovalenko TA; Center for Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Moscow, Russia.; National Medical Research Centre of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Moscow, Russia.

Subjects: Factor X*/Factor X*/Factor X*/metabolism ; Thromboplastin*/Thromboplastin*/Thromboplastin*/metabolism; Factor VIIa/Factor VIIa/Factor VIIa/metabolism

  • Source: International journal for numerical methods in biomedical engineering [Int J Numer Method Biomed Eng] 2023 Nov; Vol. 39 (11), pp. e3689. Date of Electronic Publication: 2023 Feb Publisher: Wiley Country of Publication: England NLM ID: 101530293 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2040-7947

Record details

Read More Add to Saved list
×
Academic Journal

Factor X inhibitors: A seldom seen but important antibody mediated process.

Subjects: Factor X* ; Antibodies*; Humans

  • Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2023 Sep; Vol. 29 (5), pp. 1175. Date of Electronic Publication: 2023 Aug 30.Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  144,722 results for ""Factor X""